Cellular apoptosis · target hub

TNFRSF10A

TNFRSF10A (TNFRSF10A)

TNFRSF10A is a Death receptor / DISC on the Apoptosis signaling pathway axis. Validate with UniProt and literature. Indexed under "Death receptors" for antibodies and assay guidance.

Research notes

  • Combine with module neighbors to test non-redundant roles of TNFRSF10A.
  • Pair phospho/phenotypic readouts with stimulation and inhibitor controls.
  • Validate antibody clone and compartment; include KD/KO controls.

On the pathway hub (sections)

Genetic lesions & expression context (quick reference)

Type / exampleDomain / context (brief)
Expression contextTissue/cell-type–dependent expression
Rare variantsSporadic variants—require validation
Pathway couplingCo-occurs with neighboring nodes

Naming and prevalence vary—annotate clinically with authoritative databases.

Assay readouts for TNFRSF10A

  • DISC assembly (FADD, caspase-8 recruitment) IP/IF.
  • Death-ligand stimulation (FasL, TRAIL, TNF).
  • Type II tBID–mitochondrial coupling.
  • cIAP/XIAP regulation of caspases.

TNFRSF10A experimental notes

Examples below reflect common literature and public resources (e.g., CCLE, DepMap)—validate genotypes, expression, and passage in your own stocks before committing assays.

[1] Cell lines commonly used for TNFRSF10A studies (examples)

  • Tool lines: Jurkat, HeLa, A549—screen by TNFRSF10A expression (CCLE/DepMap).
  • Combine with neighbors (FAS, TNFRSF10B, TNFRSF1A, TNFRSF25) via KD/pharmacology.
  • Overexpression/rescue in HEK293T supports mechanism and IP.
  • Isogenic/CRISPR models separate dependency from bypass.

[2] Cell samples for TNFRSF10A Western blot

  • Whole-cell lysates; phosphatase inhibitors for phospho blots.
  • Optimize stimulation time courses per ligand/stress.
  • Controls: KD/KO or inhibitors.
  • BCA normalization; subcellular fractionation when needed.

[3] Tissue samples for TNFRSF10A Western blot

  • Matched tumor/adjacent frozen tissues.
  • Mouse models—mind species cross-reactivity.
  • Primary cells/PDCs when approved.
  • FFPE needs specialized extraction; frozen preferred for phospho.

[4] Cell samples for TNFRSF10A immunoprecipitation

  • Tagged overexpression: HEK293T FLAG/HA-TNFRSF10A.
  • Endogenous IP: high-expression lines.
  • Stimulation enriches interactions.
  • Controls: isotype IgG, empty vector, KO.

Human tissues and primary cells require ethics/IRB approval; tumors are heterogeneous—record histotype, site, and preservation conditions.

Bypass & related pathways

Models & genetics note

Overexpression vs endogenous TNFRSF10A can differ in dosage, splicing, and compartmentation.

Quick search presets

TNFRSF10A-related antibodies (keyword-biased)

Adds TNFRSF10A keyword bias atop the 凋亡信号通路 antibody pool—if sparse, use presets above or global search.

FAQ

This content supports research reagents and pathway education—not medical advice. Annotate mutations, drug indications, and protocols with authoritative databases, datasheets, and institutional oversight.

Last reviewed: 2026-05-18

Related on this site

See the cellular apoptosis hub for neighboring targets—cross-check PI3K, MAPK, and transmembrane transport pages as needed.